Clincosm LogoSign in Get a demo

TBIDU: Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients

Sponsor
National Institute for Health Development, Estonia (Other)
Overall Status
Completed
CT.gov ID
NCT01290081
Collaborator
LLC Corrigo (Other), Ida-Viru Central Hospital, Department of Tuberculosis (Other)
112
Enrollment
1
Location
2
Arms
3
Duration (Months)
37.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Condition or Disease Intervention/Treatment Phase
  • Other: Case management approach in referral to health care services
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment
Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Jan 1, 2008
Actual Study Completion Date :
Jan 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active referral

Case management intervention group - study personnel scheduled the TB doctor appointment for the participant, reminded to keep it, and transportation to the clinic was organized when needed.

Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program
No Intervention: Passive referral

Participants were instructed to schedule an appointment with TB services themselves.

Other: Case management approach in referral to health care services
Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • Participation in substitution treatment program,

    • Age 18 years or more,

    • Able to read and write in Estonian or Russian,

    • Able to provide informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 LLC Corrigo Jõhvi Ida-Virumaa Estonia 41532

    Sponsors and Collaborators

    • National Institute for Health Development, Estonia
    • LLC Corrigo
    • Ida-Viru Central Hospital, Department of Tuberculosis

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01290081
    Other Study ID Numbers:
    • TBIDU-1230
    First Posted:
    Feb 4, 2011
    Last Update Posted:
    Feb 4, 2011
    Last Verified:
    Jan 1, 2008
    Keywords provided by , ,
    Tuberculosis
    Injecting drug users
    Case management
    Additional relevant MeSH terms:
    Tuberculosis

    Study Results

    No Results Posted as of Feb 4, 2011